ArticleFrontiers in cardiovascular medicine2026
Further optimization of an ADMA Biologic's proprietary manufacturing process to ensure removal of impurities associated with thrombosis risk in IVIG products.
Kaitlin Kestenberg et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.